Results 121 to 130 of about 19,829 (313)
Marketing Strategies in Nanomaterials for Sensor Applications: Bridging Lab to Market
Global Challenges, EarlyView.This work discusses strategies for the successful commercialization of nanomaterial‐based sensors, including regulatory compliance and industry collaboration. It highlights unique value propositions, intellectual property protection, and customer education to enhance market acceptance.
Anoop Singh +9 more
wiley +1 more source
Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment [PDF]
International Journal of Molecular Sciences, 2019 Current cancer therapeutics suffer from a lack of specificity in targeting tumor cells and cause severe side effects. Therefore, the design of highly specialized drugs comprising antibody derivatives inducing apoptosis in targeted cancer cells is considered to be a promising strategy.
Golnaz Sadeghnezhad +6 more
openaire +4 more sources
Food and Agricultural Immunology, 2020 Anti-idiotypic antibody technology has been widely developed. Here, we prepared the F(ab’)2 fragments of the Cry1F toxin polyclonal antibody as Ab1and screened an anti-idiotype nanobody (VHH) for Bt Cry1F toxin from the camelid naive antibody phage ...
Jia Hao +9 more
doaj +1 more source
A hitchhiker's guide to single‐cell epigenomics: Methods and applications for cancer research
International Journal of Cancer, EarlyView.Abstract Genetic mutations are well known to influence tumorigenesis, tumor progression, treatment response and relapse, but the role of epigenetic variation in cancer progression is still largely unexplored. The lack of epigenetic understanding in cancer evolution is in part due to the limited availability of methods to examine such a heterogeneous ...
Marta Moreno‐Gonzalez +2 more
wiley +1 more source
PLoS ONE, 2014 Environmental and genetic activation of a brain-adipocyte axis inhibits cancer progression. Leptin is the primary peripheral mediator of this anticancer effect in a mouse model of melanoma.
Travis McMurphy +6 more
doaj +1 more source
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain Antibody. [PDF]
Adv Sci (Weinh)Several methods have been used to label antibodies to facilitate visualization of cognate targets. Here, we leverage a new variety of conjugation chemistry, based on a crosslinking nanobody, to label target‐specific nanobody constructs with functionalities of choice.
Fayn S +12 more
europepmc +2 more sources
arXiv, 2005 This chapter deals with atom-wall interaction occurring in the "long-range" regime (typical distances: 1-1000 nm), when the electromagnetic fluctuations of an isolated atom are modified by the vicinity with a surface. Various regimes of interaction are discussed in an Introductory part, from Cavity Quantum ElectroDynamics modifications of the ...
arxiv
Nanomaterials for acute myeloid leukemia therapy: Current progress and future perspectives
Interdisciplinary Medicine, EarlyView.Infographics of this review introducing the current treatment strategies, types of nanomaterials, and their advantages in AML treatment (Created with BioRender.com, a license purchased, accessed on March 26, 2024). Abstract Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by poor prognosis, high relapse rates ...
Jiarui Zhao +8 more
wiley +1 more source
Evaluation of antidiphtheria toxin nanobodies
Nanotechnology, Science and Applications, 2010 Nanobodies are the smallest fragments of naturally occurring single-domain antibodies that have evolved to be fully functional in the absence of a light chain. Conventional antibodies are glycoproteins comprising two heavy and two light chains. Surprisingly, all members of the Camelidae family possess a fraction of antibodies devoid of both light ...
openaire +5 more sources
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
International Journal of Nanomedicine, 2016 Yongzhong Wang,1 Zhen Fan,2 Lei Shao,3 Xiaowei Kong,1 Xianjuan Hou,1 Dongrui Tian,1 Ying Sun,1 Yazhong Xiao,1 Li Yu4 1School of Life Sciences, Collaborative Innovation Center of Modern Bio-manufacture, Anhui University, Hefei, People’s Republic of
Wang Y +8 more
doaj